|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 69/602 | (2006.01) |
| C07C 57/03 | (2006.01) | ||
| C07C 57/13 | (2006.01) | ||
| A61K 31/11 | (2006.01) | ||
| A61K 31/202 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2540696 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12166293.6 |
| Date of filing the European patent application | 2006-02-24 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 655422 P | 2005-02-24 | US |
| (72) |
Gainer, John, L., US
Lanz, Marc, CH
|
| (73) |
Diffusion Pharmaceuticals LLC,
999 Grove Street, Suite 203, Charlottesville, VA 22902,
US
|
| (54) | Trans carotenoids, formulation and uses |
| Trans carotenoids, formulation and uses |